Skip to Main Content
Contribute Try STAT+ Today

The public outcry to “do something” about health care spending keeps growing, but fear about what that might entail stymies action. Americans need affordable, accessible, and innovative health care. They don’t need rationing of treatments or a regime of price controls that could hobble medical progress.

Finding policy solutions — and building support for them — is a formidable task. An important first step that can be taken without risking heavy-handed intervention is for Congress to establish an independent Institute of Health Technology Assessment.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!


What is it?

STAT+ is STAT's premium subscription service for in-depth biotech, pharma, policy, and life science coverage and analysis. Our award-winning team covers news on Wall Street, policy developments in Washington, early science breakthroughs and clinical trial results, and health care disruption in Silicon Valley and beyond.

What's included?

  • Daily reporting and analysis
  • The most comprehensive industry coverage from a powerhouse team of reporters
  • Subscriber-only newsletters
  • Daily newsletters to brief you on the most important industry news of the day
  • STAT+ Conversations
  • Weekly opportunities to engage with our reporters and leading industry experts in live video conversations
  • Exclusive industry events
  • Premium access to subscriber-only networking events around the country
  • The best reporters in the industry
  • The most trusted and well-connected newsroom in the health care industry
  • And much more
  • Exclusive interviews with industry leaders, profiles, and premium tools, like our CRISPR Trackr.
  • This is an interesting proposal but it’s far from novel. The UK was the first to set up such an institution, NICE, National Institute for Clinical Excellence, and many European countries have followed suit. It has been an important means to address drug pricing and reimbursement questions and ensure value added for patients. Your article should have acknowledged these previous efforts. That’s good professional and scientific practice.

Comments are closed.